23rd September 2021

BridgeTech Program - Now Open

A professional development program for effectively navigating the medtech commercialisation pathway.

Latest News

9 October 2014

Janet Davies on ABC 612 discussing Hayfever

Millions of Australian suffer from hayfever, and allergy to grass pollen is a common culprit. We speak to two pollen researchers about a new allergy t
More about Janet Davies on ABC 612 discussing Hayfever
9 October 2014

TRI discusses the latest in the war against obesity

The Translation Research Institute (TRI), Australia’s most innovative biomedical research facility, will hold a Café Scientifique Sunday 12 October.
More about TRI discusses the latest in the war against obesity
3 October 2014

Herpes Simplex vaccine development passes first trial

Professor Ian Frazer has had early success in trials for a new vaccine to treat the herpes simplex virus.
More about Herpes Simplex vaccine development passes first trial
2 October 2014

New hay fever blood test nothing to sneeze at

Researchers have developed a blood test that can accurately detect one of the commonest causes of hay fever, paving the way for new treatments.
More about New hay fever blood test nothing to sneeze at
1 October 2014

New gene research helps pinpoint prostate cancer risk

Worldwide team of researchers carry out the largest-ever analysis of the cancer's genetic biomarkers to help better predict risk of prostate cancer.
More about New gene research helps pinpoint prostate cancer risk
19 September 2014

New CEO for Translational Research Institute

Professor Carolyn Mountford will be the new CEO and Director of Research for TRI, taking over from Professor Ian Frazer in February 2015.
More about New CEO for Translational Research Institute

Pages